Valuation : Nexentis Technologies Inc.

Market Cap 25L 21.5L 20.22L 18.46L 34.52L 24Cr 34.63L 2.4Cr 92.67L 12Cr 93.87L 91.82L 39Cr P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value -6L -5L -5L -4L -8L -5.48Cr -8L -55.55L -21.47L -2.81Cr -21.75L -21.28L -8.94Cr EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
78.83%
Yield 2024 *
-
Yield 2025 -
1 day+2.38%
1 week-4.44%
Current month-4.44%
1 month-8.99%
3 months-70.34%
6 months-73.00%
Current year-85.37%
1 week 1.61
Extreme 1.61
1.89
1 month 1.61
Extreme 1.61
2.05
Current year 1.43
Extreme 1.4301
23.8
1 year 1.43
Extreme 1.4301
58.75
3 years 1.43
Extreme 1.4301
1,849.73
5 years 1.43
Extreme 1.4301
16,464.03
10 years 1.43
Extreme 1.4301
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 05/11/2020
Director of Finance/CFO 39 18/04/2022
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 53 26/08/2020
Chairman 62 24/05/2021
Director/Board Member 54 26/08/2020
Date Insider Type Main position Quantity % Market Cap. Importance
09/02/26 Free

Chief Financial Officer

50,000 1.8639%
09/02/26 Free

Chairman

1,16,286 4.3350%
09/02/26 Free

Chief Executive Officer

1,00,000 3.7279%
Change 5-day change 1-year change 3-year change Capi.($)
+2.38%-4.44%-96.92%-99.82% 25L
-0.86%+3.82%+21.52%+77.28% 5.86TCr
+0.11%-.--%-.--%-.--% 1.3TCr
+1.31%+4.51%+31.98%+196.51% 1.15TCr
-1.49%-3.50%+15.45%+72.78% 824.03Cr
+0.69%+2.62%-3.45%+2.09% 757.65Cr
+4.61%+7.20%+63.18%+74.05% 611.3Cr
+0.22%-2.40%-18.55%+53.58% 542.77Cr
-0.16%+1.63%-18.58%-5.24% 514.27Cr
-0.85%+0.98%-34.69%-34.01% 390.12Cr
Average +0.60%+1.16%-4.01%+33.72% 1.19TCr
Weighted average by Cap. -0.13%+3.30%+14.93%+66.81%

Financials

2024 2025
Net sales 2L 2L 2L 2L 3L 1.99Cr 3L 20.14L 8L 1.02Cr 8L 8L 3.24Cr -
Net income -51.93L -44.66L -42L -38.34L -71.71L -49Cr -71.94L -4.98Cr -1.93Cr -25Cr -1.95Cr -1.91Cr -80Cr -40.04L -34.43L -32.39L -29.56L -55.29L -38Cr -55.47L -3.84Cr -1.48Cr -19Cr -1.5Cr -1.47Cr -62Cr
Net Debt -24.85L -21.37L -20.1L -18.35L -34.32L -24Cr -34.43L -2.38Cr -92.12L -12Cr -93.32L -91.28L -38Cr -30.79L -26.48L -24.9L -22.73L -42.52L -29Cr -42.66L -2.95Cr -1.14Cr -15Cr -1.16Cr -1.13Cr -47Cr
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
04/26/04 $1.720 +2.38% 10,136
03/26/03 $1.680 -2.33% 19,779
02/26/02 $1.720 -2.27% 31,988
01/26/01 $1.760 -2.22% 18,019
  1. Stock Market
  2. Stocks
  3. NXTS Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!